"Asked about the copies identified by Reuters, Eli Lilly said tirzepatide was a complex macromolecule that required rigorous testing.
“Any policies for approval of biosimilar products…present significant patient safety concerns. Regulators should proceed carefully, with patient safety at the forefront,” Lilly said in a written statement."
Of course they say that, that’s their goose that lays golden eggs
These protein-based drugs are pretty easy to make, that’s why these are available easily on grey market.
Interesting story. I guess I had no idea that this was all legal and that countries were exempt from patent law.
I wonder how well the tablet forms work?
They don’t work (with the exception of branded Rybelsus tablets, of course).
Are you guessing or do you know this to be true?
The molecules are too big for oral absorption, which is why Rybelsus has a patented penetration enhancer (called SNAC) that allows a small % of it to cross the stomach wall directly.
My wife and I also tried a compounded sublingual tirzepatide which had zero effect. Compounded oral versions would have taken over the market by now if they did anything.